Sponsored by the Friends of NIMH, in conjunction with the Congressional Mental Health Caucus

The briefing will feature an expert panel presenting research on two innovative models of learning health care systems to improve care and outcomes and advance science. By collecting and sharing data in coordinated and privacy-protected ways, the National Institute of Mental Health (NIMH)-funded Early Psychosis Intervention Network (EPINET) enables partnership among clients and their families, clinicians, health care administrators, and scientific experts to improve early psychosis care and conduct large-scale, practice-based research. The Accelerating Medicines Partnership® in Schizophrenia (AMP® SCZ) is a public-private partnership focused on generating biomarkers, prediction models, and other tools to accelerate the development of early-stage interventions for patients who are at risk of developing schizophrenia. Such tools will help identify and test novel treatment approaches to prevent or delay the onset of psychosis in at-risk individuals.

Please register here for the briefing.